The APAC lateral flow diagnostic tests market is expected to grow at a moderate rate due to rising prevalence of infectious diseases, increasing government initiatives and product innovation by various medical companies.
Albany, NY -- (SBWIRE) -- 02/10/2016 -- This report on the APAC lateral flow diagnostic tests market studies the current and future prospects of the global market. Lateral flow tests are performed to detect the presence of target analyte in the sample and are also known as lateral flow immunotechnology assays. Such tests are used for medical diagnostics either for home testing, point of care testing, or laboratory use. Growing incidences of infectious diseases, changing lifestyle of the APAC population and increasing government support is expected to accentuate the growth of lateral flow diagnostic tests market.
Complete Report with TOC @ http://www.mrrse.com/apac-lateral-flow-diagnostic-tests-market
The APAC lateral flow diagnostic tests market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the APAC lateral flow diagnostic tests market with respect to market segments based on application and country analysis.
Based on application, the APAC lateral flow diagnostic tests market have been segmented into pregnancy, hepatitis, HIV, influenza, syphilis, malaria, and others which includes lung disorders, cardiac markers, drug abuse, etc. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the volume and compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2013 and 2014 as the base years.
Geographically, the APAC lateral flow diagnostic tests market has been categorized into 14 major countries: China, India, South Korea, Indonesia, Australia, Japan, Malaysia, Philippines, Singapore, New Zealand, Vietnam, Bangladesh, Pakistan, and Rest of APAC. The market size and forecast for each of these regions has been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides Porter's Five Forces analysis, and heat map analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the APAC lateral flow diagnostic tests market.
Request a Free Sample Copy of the Report @ http://www.mrrse.com/sample/1539
A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the APAC lateral flow diagnostic tests market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Alere, Inc., Beckman Coulter, Inc., Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, EMD Millipore, F. Hoffmann-La Roche Ltd., Siemens Healthcare, and QIAGEN.
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.